BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smits A, Annaert P, Allegaert K. Drug disposition and clinical practice in neonates: Cross talk between developmental physiology and pharmacology. International Journal of Pharmaceutics 2013;452:8-13. [DOI: 10.1016/j.ijpharm.2012.03.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Smits A, De Cock PAJG. Antibiotic PK/PD research in critically ill neonates and children: how do we proceed? International Journal of Pharmacokinetics 2018;3:1-3. [DOI: 10.4155/ipk-2017-0019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Fattah S, Augustijns P, Annaert P. Age-dependent activity of the uptake transporters Ntcp and Oatp1b2 in male rat hepatocytes: from birth till adulthood. Drug Metab Dispos. 2015;43:1-8. [PMID: 25305012 DOI: 10.1124/dmd.114.059212] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ku LC, Smith PB. Dosing in neonates: special considerations in physiology and trial design. Pediatr Res 2015;77:2-9. [PMID: 25268145 DOI: 10.1038/pr.2014.143] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 7.6] [Reference Citation Analysis]
4 Neal-kluever A, Fisher J, Grylack L, Kakiuchi-kiyota S, Halpern W. Physiology of the Neonatal Gastrointestinal System Relevant to the Disposition of Orally Administered Medications. Drug Metab Dispos 2019;47:296-313. [DOI: 10.1124/dmd.118.084418] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
5 Imaz ML, Oriolo G, Torra M, Soy D, García-Esteve L, Martin-Santos R. Clozapine Use During Pregnancy and Lactation: A Case-Series Report. Front Pharmacol 2018;9:264. [PMID: 29636684 DOI: 10.3389/fphar.2018.00264] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
6 Leroux S, Zhao W, Bétrémieux P, Pladys P, Saliba E, Jacqz-Aigrain E; French Society of Neonatology. Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey. Arch Dis Child 2015;100:394-8. [PMID: 25628457 DOI: 10.1136/archdischild-2014-306873] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
7 Abrams EJ, Ananworanich J, Archary M, Ngongondo M, Brouwers P. Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration. J Acquir Immune Defic Syndr 2018;78 Suppl 1:S32-9. [PMID: 29994918 DOI: 10.1097/QAI.0000000000001747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
8 Penazzato M, Sugandhi N, Essajee S, Doherty M, Ficht A, Phelps BR. Getting Treatment and Care Services Right for Children and Adolescents to Reach High Viral Suppression. J Acquir Immune Defic Syndr 2018;78 Suppl 2:S128-33. [PMID: 29994835 DOI: 10.1097/QAI.0000000000001738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hulverson MA, Vinayak S, Choi R, Schaefer DA, Castellanos-Gonzalez A, Vidadala RSR, Brooks CF, Herbert GT, Betzer DP, Whitman GR, Sparks HN, Arnold SLM, Rivas KL, Barrett LK, White AC Jr, Maly DJ, Riggs MW, Striepen B, Van Voorhis WC, Ojo KK. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. J Infect Dis 2017;215:1275-84. [PMID: 28329187 DOI: 10.1093/infdis/jix120] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
10 Vinarov Z, Abdallah M, Agundez JAG, Allegaert K, Basit AW, Braeckmans M, Ceulemans J, Corsetti M, Griffin BT, Grimm M, Keszthelyi D, Koziolek M, Madla CM, Matthys C, McCoubrey LE, Mitra A, Reppas C, Stappaerts J, Steenackers N, Trevaskis NL, Vanuytsel T, Vertzoni M, Weitschies W, Wilson C, Augustijns P. Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. Eur J Pharm Sci 2021;162:105812. [PMID: 33753215 DOI: 10.1016/j.ejps.2021.105812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
11 Smits A, De Cock P, Vermeulen A, Allegaert K. Physiologically based pharmacokinetic (PBPK) modeling and simulation in neonatal drug development: how clinicians can contribute. Expert Opin Drug Metab Toxicol 2019;15:25-34. [PMID: 30554542 DOI: 10.1080/17425255.2019.1558205] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
12 Vandendriessche A, Allegaert K, Cossey V, Naulaers G, Saegeman V, Smits A. Prospective validation of neonatal vancomycin dosing regimens is urgently needed. Curr Ther Res Clin Exp 2014;76:51-7. [PMID: 25061483 DOI: 10.1016/j.curtheres.2014.06.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
13 Bhosle VK, Altit G, Autmizguine J, Chemtob S. Basic Pharmacologic Principles. Fetal and Neonatal Physiology. Elsevier; 2017. pp. 187-201.e3. [DOI: 10.1016/b978-0-323-35214-7.00018-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Rivera-Chaparro ND, Cohen-Wolkowiez M, Greenberg RG. Dosing antibiotics in neonates: review of the pharmacokinetic data. Future Microbiol 2017;12:1001-16. [PMID: 28758800 DOI: 10.2217/fmb-2017-0058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Allegaert K, Smits A, van Donge T, van den Anker J, Sarafidis K, Levtchenko E, Mekahli D. Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions. Front Pediatr 2020;8:366. [PMID: 32850523 DOI: 10.3389/fped.2020.00366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
16 Brouwer KL, Aleksunes LM, Brandys B, Giacoia GP, Knipp G, Lukacova V, Meibohm B, Nigam SK, Rieder M, de Wildt SN; Pediatric Transporter Working Group. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group. Clin Pharmacol Ther 2015;98:266-87. [PMID: 26088472 DOI: 10.1002/cpt.176] [Cited by in Crossref: 113] [Cited by in F6Publishing: 91] [Article Influence: 18.8] [Reference Citation Analysis]
17 Allegaert K, van den Anker J. Dose-Related Adverse Drug Events in Neonates: Recognition and Assessment. J Clin Pharmacol 2021;61 Suppl 1:S152-60. [PMID: 34185907 DOI: 10.1002/jcph.1827] [Reference Citation Analysis]
18 Job KM, Gamalo M, Ward RM. Pediatric Age Groups and Approach to Studies. Ther Innov Regul Sci 2019;53:584-9. [PMID: 31311309 DOI: 10.1177/2168479019856572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Duan P, Fisher JW, Wang J. Applications of Physiologically Based Pharmacokinetic (PBPK) Models for Pediatric Populations. In: Mahmood I, Burckart G, editors. Fundamentals of Pediatric Drug Dosing. Cham: Springer International Publishing; 2016. pp. 109-25. [DOI: 10.1007/978-3-319-43754-5_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
20 van Groen BD, Nicolaï J, Kuik AC, Van Cruchten S, van Peer E, Smits A, Schmidt S, de Wildt SN, Allegaert K, De Schaepdrijver L, Annaert P, Badée J. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species. Pharmacol Rev 2021;73:597-678. [PMID: 33608409 DOI: 10.1124/pharmrev.120.000071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
21 Schulz J, Kluwe F, Mikus G, Michelet R, Kloft C. Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism. Drug Metab Rev 2019;51:247-65. [PMID: 31215810 DOI: 10.1080/03602532.2019.1632888] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
22 Smits A, Annaert P, Van Cruchten S, Allegaert K. A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates. Front Pharmacol 2020;11:587. [PMID: 32477113 DOI: 10.3389/fphar.2020.00587] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
23 Rosebush JC, Best BM, Chadwick EG, Butler K, Moye J, Smith E, Bradford S, Reding CA, Mathiba SR, Hanley S, Aziz M, Homans J, Acosta EP, Murtaugh W, Vourvahis M, Mcfadyen L, Hayward K, Mirochnick M, Samson P; IMPAACT 2007 Study Team. Pharmacokinetics and safety of maraviroc in neonates. AIDS 2021;35:419-27. [PMID: 33252481 DOI: 10.1097/QAD.0000000000002762] [Reference Citation Analysis]
24 Leroux S, Jacqz-Aigrain E, Biran V, Lopez E, Madeleneau D, Wallon C, Zana-Taïeb E, Virlouvet AL, Rioualen S, Zhao W. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates. Antimicrob Agents Chemother 2016;60:2039-42. [PMID: 26787690 DOI: 10.1128/AAC.02214-15] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
25 Ruggiero A, Ariano A, Triarico S, Capozza MA, Ferrara P, Attinà G. Neonatal pharmacology and clinical implications. Drugs Context 2019;8:212608. [PMID: 31692800 DOI: 10.7573/dic.212608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
26 Aleem S, Wohlfarth M, Cotten CM, Greenberg RG. Infection control and other stewardship strategies in late onset sepsis, necrotizing enterocolitis, and localized infection in the neonatal intensive care unit. Semin Perinatol 2020;44:151326. [PMID: 33158599 DOI: 10.1016/j.semperi.2020.151326] [Reference Citation Analysis]
27 Clarke DF, Penazzato M, Capparelli E, Cressey TR, Siberry G, Sugandhi N, Mirochnick M; WHO Paediatric Antiretroviral Working Group. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations. Expert Rev Clin Pharmacol 2018;11:83-93. [PMID: 29039686 DOI: 10.1080/17512433.2018.1393331] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
28 De Cock RF, Smits A, Allegaert K, de Hoon J, Saegeman V, Danhof M, Knibbe CA. Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates. J Antimicrob Chemother 2014;69:1330-8. [PMID: 24492261 DOI: 10.1093/jac/dkt527] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
29 Penazzato M, Gnanashanmugam D, Rojo P, Lallemant M, Lewis LL, Rocchi F, Saint Raymond A, Ford N, Hazra R, Giaquinto C, Belew Y, Gibb DM, Abrams EJ; Paediatric Antiretroviral Working Group (PAWG). Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations. Clin Infect Dis 2017;64:1597-603. [PMID: 29190337 DOI: 10.1093/cid/cix194] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]